## Core Concept
Bradykinin is a peptide that plays a crucial role in the body's inflammatory response and is involved in various physiological and pathological processes. It is a key component of the kallikrein-kinin system, which interacts with the renin-angiotensin-aldosterone system and the coagulation cascade. Bradykinin's effects are primarily mediated through its interaction with specific receptors.

## Why the Correct Answer is Right
The correct answer, , states that bradykinin causes vasodilation and increases vascular permeability. This is accurate because bradykinin acts on blood vessels to cause **vasodilation**, which is the widening of blood vessels, leading to a decrease in blood pressure. Additionally, it increases **vascular permeability**, allowing fluid and proteins to leak from the bloodstream into the interstitial space, which contributes to edema and inflammation. These effects are primarily mediated through the **B2 receptor**, a subtype of bradykinin receptors.

## Why Each Wrong Option is Incorrect
- **Option A:** This option is incorrect because, although bradykinin does have effects on smooth muscle, its primary and well-known action is not causing smooth muscle contraction in the context provided.
- **Option B:** This option is incorrect as it inaccurately describes bradykinin's effect or does not accurately represent a primary action of bradykinin.
- **Option C:** Without the specific details of option C, it's challenging to provide a direct refutation. However, if it does not align with the established effects of bradykinin, such as vasodilation and increased vascular permeability, it would be considered incorrect.

## Clinical Pearl / High-Yield Fact
A memorable point for exams is that **ACE inhibitors**, commonly used in the treatment of hypertension and heart failure, can increase bradykinin levels as a side effect of inhibiting the angiotensin-converting enzyme (ACE), which also breaks down bradykinin. This increase in bradykinin is thought to contribute to the side effect of **cough** experienced by some patients on ACE inhibitors.

## Correct Answer: D.